Humpton, Timothy J.
Hock, Andreas K.
Maddocks, Oliver D. K.
Vousden, Karen H. http://orcid.org/0000-0002-7365-1766
Funding for this research was provided by:
Cancer Research UK (C596/A10418, C596/A26855, C53309/A19702)
European Research Council (322842-METABOp53)
Francis Crick Institute (FC001557)
Article History
Received: 15 August 2018
Accepted: 8 October 2018
First Online: 3 December 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: KV is on the Board of Directors and shareholder of Bristol Myers Squib, on the Advisory Board and shareholder of Grail Inc., and on the advisory board of PMV Pharma and RAZE therapeutics. ODKM and KHV are inventors on CRUK Patent Application WO/2017/144877.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.